410.19MMarket Cap-10.43P/E (TTM)
4.680High4.320Low574.87KVolume4.400Open4.360Pre Close2.62MTurnover0.95%Turnover RatioLossP/E (Static)89.37MShares4.68052wk High6.95P/B276.55MFloat Cap1.27052wk Low--Dividend TTM60.25MShs Float10.620Historical High--Div YieldTTM8.26%Amplitude0.460Historical Low4.556Avg Price1Lot Size
Trevi Therapeutics Stock Forum
📊⚡️📊
Trevi Therapeutics Announces Positive Outcome from Sample Size Re-estimation Resulting in No Change to the Current Sample Size for the Phase 2b CORAL Trial in Idiopathic Pulmonary Fibrosis Patients with Chronic Cough
Thursday, 12th December at 7:30 am
Independent Data Monitoring Statistician reaffirmed current sample size to remain at N=160
The trial has reached 75% of the targeted enrollment, and topline results continue to be expected in the first half of 20...
Trevi Therapeutics Announces Positive Outcome From SAMPLE Size Re-Estimation Resulting in No Change to the Current SAMPLE Size for the Phase 2B Coral Trial in Idiopathic Pulmonary Fibrosis Patients With Chronic Cough
No comment yet